-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: BIOtechNOW Editor
BIO Career Fair: Impress the best
Don’t miss an opportunity to spend a day with hiring managers from the nations’ top biotech firms on April 22 at the BIO Career Fair in Chicago. We asked Chanille Hewett, Product Manager for BioSpace , host of the BIO Career Fair, to share some ideas on how job seekers can benefit most from attending. You can pre-register online right now. It’s easy and will save you time at the event. Why should a job Read More >
GEN’s “Top 10” Session Picks for the 2013 BIO International Convention
As the industry moves forward in 2013, it again faces one of its regular bugaboos—uncertainty. “Where are we headed?” has been a standard phrase among bioindustry observers since the early 1980s. As it turns out, the biopharmaceutical business must once again deal with a number of important issues this year. For example, G. Steven Burrill, CEO of Burrill & Co., points out that the cuts mandated by the U.S. Congress’ sequestration fiscal policy may slow Read More >
Psoriasis Patients Flock to Social Media for Practical Info
About eight in 10 psoriasis patients who use health care social networks say they do so primarily to learn how others manage their disease, and get practical tips and advice they couldn’t find elsewhere, according to a survey conducted by the National Psoriasis Foundation, Manhattan Research and Inspire, a company that builds and manages online patient communities. The millions of people with psoriasis, including the one million visitors to TalkPsoriasis in 2012, are not alone Read More >
The Michael J. Fox Foundation Launches New Funding Opportunities
The Michael J. Fox Foundation (MJFF) is committed to sharing the risk of drug development with researchers from academia and industry alike in order to keep promising research moving forward along the Parkinson’s disease (PD) drug pipeline. To date, MJFF has funded over $300 million in research, $83 million of which has been awarded to more than 180 unique, industry-led projects. On February 20, MJFF launched nine funding programs, three of which are new to Read More >
Navigating the Rare Disease World
The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled by the entrance of big pharmaceutical companies and U.S. legislation favoring development and coverage. This growth promises to improve the health of patients with debilitating and life-threatening disorders. Hoping to further the rare disease dialogue and relationship building opportunities, the 2013 Orphan Disease Forum will provide unique perspective on the orphan drug marketplace, regulatory considerations and much more. Operating within Read More >
